Literature DB >> 17357613

The incidence of jaw osteonecrosis in multiple myeloma patients treated with bisphosphonates.

Maria Kraj1, Ryszard Pogłód, Stanisław Maj, Katarzyna Owczarska.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17357613

Source DB:  PubMed          Journal:  Acta Pol Pharm        ISSN： 0001-6837            Impact factor:   0.330


× No keyword cloud information.
  2 in total

1.  Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates.

Authors:  Ana O Hoff; Béla B Toth; Kadri Altundag; Marcella M Johnson; Carla L Warneke; Mimi Hu; Ajay Nooka; Gilbert Sayegh; Valentina Guarneri; Kimberly Desrouleaux; Jeffrey Cui; Andrea Adamus; Robert F Gagel; Gabriel N Hortobagyi
Journal:  J Bone Miner Res       Date:  2008-06       Impact factor: 6.741

2.  State of oral mucosa as an additional symptom in the course of primary amyloidosis and multiple myeloma disease.

Authors:  Maciej R Czerniuk; Artur Jurczyszyn; Grzegorz Charlinski
Journal:  Case Rep Med       Date:  2014-06-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.